Global Nuclear Medicine or Radiopharmaceuticals Market Research Report 2022 - Market Size, Current Insights and Development Trends

Global Nuclear Medicine or Radiopharmaceuticals Market Research Report 2022 - Market Size, Current Insights and Development Trends

The report focuses on the Nuclear Medicine or Radiopharmaceuticals market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Nuclear Medicine or Radiopharmaceuticals market.

Major Players in the Nuclear Medicine or Radiopharmaceuticals market are:

Curium Pharma
Cardinal Health
China Isotope & Radiation Corporation
Nihon Medi-Physics Co. Ltd.
GE Healthcare
Jubilant Life Sciences
Advanced Accelerator Applications
Lantheus Medical Imaging

On the basis of types, the Nuclear Medicine or Radiopharmaceuticals market is primarily split into:

SPECT Radiopharmaceuticals (Diagnostics)
PET Radiopharmaceuticals (Diagnostics)
Beta Emitters (Therapeutics)
Alpha Emitters (Therapeutics)
Brachytherapy Isotopes (Therapeutics)

On the basis of applications, the market covers:

Oncology
Cardiology
Thyroid

Major Regions or countries covered in this report:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029